2009 | 2008 | 2007 | 2006 | 2005 |  2004 | 2003 |  2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | AllPubMed

Publications - 2008

Guglieri S, Hricovini M, Raman R, Polito L, Torri G, Casu B, Sasisekharan R, and Guerrini M. Minimum FGF2 Binding Structural Requirements of Heparin and Heparan Sulfate Oligosaccharides As Determined by NMR Spectroscopy. Biochemistry 2008 Dec 30; 47(52):13862-9

Blossom DB, Kallen AJ, Patel PR, Elward A, Robinson L, Gao G, Langer R, Perkins KM, Jaeger JL, Kurkjian KM, Jones M, Schillie SF, Shehab N, Ketterer D, Venkataraman G, Kishimoto TK, Shriver Z, McMahon AW, Austen KF, Kozlowski S, Srinivasan A, Turabelidze G, Gould CV, Arduino MJ, and Sasisekharan R. Outbreak of Adverse Reactions Associated with Contaminated Heparin.” N Engl J Med 2008 Dec 18; 359(25):26474-84.

Ban Z, Bosques CJ, and Sasisekharan R. “ A simple assay to probe disease-associated enzyme activity using glycosaminoglycan-assisted synthesized gold nanaoparticles.” Org Biomol Chem 2008 Dec 7; 6(23):4290-2.

Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Dal Pan GJ, Shriver Z, Langer RS, Venkataraman G, Austen KF, Woodcock J, and Sasisekharan R. “Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System.” N Engl J Med 2008 Jun 5;358(23):2457-67

Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J, Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, and Sasisekharan R. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 2008 Jun;26(6):669-75

Srinivasan, A., Viswanathan, K., Raman, R., Chandrasekharan, A., Raguram, S., Tumpey, TM, Sasisekharan, V. and Sasisekharan, R. (2008) Quantitative Biochemical Rationale for Differences in Transmissibility of 1918 Pandemic Influenza A Viruses. Proc Natl Acad Sci USA 2008 Feb 26;105(8):2800-5

Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V & Sasisekharan R Glycan topology determines human adaptation of avian H5N1 virus hemagglutin Nat Biotechnol 2008 Jan;26(1):107-13

Packer NH, von der Lieth CW, Aoki-Kinoshita KF, Lebrilla CB, Paulson JC, Raman R, Rudd P, Sasisekharan R, Taniguchi N, York WS Frontiers in glycomics: Bioinformatics and biomarkers in disease. Proteomics 2008 Jan;8(1):8-20.

Last Updated: October 24, 2008